申请人:Combs Andrew P.
公开号:US20080119491A1
公开(公告)日:2008-05-22
The present invention is directed to amidino heterocyclic compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as to pharmaceutical compositions comprising such compounds and to pharmaceutical methods of treatment comprising administration of such compounds and pharmaceutical compositions.
本发明涉及对吲哌酮胺 2,3-双氧酶 (IDO) 的调节剂的酰胺杂环化合物,以及包含这种化合物的药物组合物和包括给予这种化合物和药物组合物的治疗药物方法。